WASHINGTON (dpa-AFX) - Medical device maker Boston Scientific Corp. (BSX) said Monday that it has become a significant shareholder and will become the exclusive worldwide sales and marketing representative for Preventice Solutions for cardiology-related diagnostic and monitoring offerings.
Through the alliance, Boston Scientific will expand its commercial presence into the $1 billion cardiac diagnostics and monitoring market by gaining access to a wireless monitoring portfolio linked to an integrated remote monitoring platform.
The relationship with Preventice Solutions reinforces Boston Scientific's commitment to demonstrating the benefits of remote monitoring for a broad range of patients.
Copyright RTT News/dpa-AFX